Total Funding
62
33
Total FundingDebt Financing raised
Growth Score
-20 pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
161969
Vascarta is a drug development company with novel transdermal technology and a seasoned management team.
- Richard Prince: Chairman, CEO & President
- Janet Loesberg: Fractional Chief Strategy OfficerPast Role: Blueprint Medicines, Senior Vice President, Global Medical Affairs
About the Company
Vascarta is a drug development company with novel transdermal technology and a seasoned management team. Their lead product candidate is designed to disrupt and redefine the standard of care in the inflammation space, a $100+ billion addressable market.
